| 12042557 |
Rapid establishment and/or termination of substantial steady-state drug delivery |
Thomas R. Alessi |
2024-07-23 |
| 10869830 |
Rapid establishment and/or termination of substantial steady-state drug delivery |
Thomas R. Alessi |
2020-12-22 |
| 10231923 |
Rapid establishment and/or termination of substantial steady-state drug delivery |
Thomas R. Alessi |
2019-03-19 |
| 8481597 |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
Jian Luo |
2013-07-09 |
| 8354448 |
Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes |
Jian Luo |
2013-01-15 |
| 8329749 |
Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia |
Jian Luo |
2012-12-11 |
| 8298561 |
Rapid establishment and/or termination of substantial steady-state drug delivery |
Thomas R. Alessi |
2012-10-30 |
| 7576131 |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
Jian Luo |
2009-08-18 |
| 6646004 |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
Jian Luo |
2003-11-11 |
| 6624194 |
Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
Jian Luo, Zuchun Zhao |
2003-09-23 |
| 6613802 |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
Jian Luo |
2003-09-02 |
| 6262118 |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
Jian Luo |
2001-07-17 |